- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $21.63M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $29.01M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.34M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $20.2M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $83.61M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $101M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $292.44M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $287.64M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $113.4M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $126.37M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $293.77M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $307.85M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 106.02M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $3.04M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$16.81M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.47 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.47 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $19.73M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.67M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$50.22M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$23.14M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $41.72M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $78.31M |
| Revenue | Q1 2025 · Mar 31, 2024 | $120.03M |